Bank of New York Mellon Corp Has $13.53 Million Stock Holdings in Oscar Health, Inc. (NYSE:OSCR)

Bank of New York Mellon Corp reduced its stake in Oscar Health, Inc. (NYSE:OSCR) by 25.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,031,827 shares of the company’s stock after selling 343,581 shares during the period. Bank of New York Mellon Corp owned 0.41% of Oscar Health worth $13,527,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Southeastern Asset Management Inc. TN lifted its holdings in shares of Oscar Health by 52.2% during the fourth quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company’s stock worth $42,082,000 after buying an additional 1,073,359 shares in the last quarter. Jacobs Levy Equity Management Inc. increased its position in Oscar Health by 37.8% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company’s stock worth $23,403,000 after acquiring an additional 477,634 shares during the period. Man Group plc raised its stake in Oscar Health by 344.8% in the 4th quarter. Man Group plc now owns 1,813,216 shares of the company’s stock worth $24,370,000 after purchasing an additional 1,405,554 shares in the last quarter. Toronto Dominion Bank acquired a new stake in Oscar Health in the 4th quarter worth about $1,008,000. Finally, Deutsche Bank AG boosted its holdings in Oscar Health by 51.2% in the 4th quarter. Deutsche Bank AG now owns 172,127 shares of the company’s stock valued at $2,313,000 after purchasing an additional 58,282 shares during the period. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

OSCR has been the topic of several recent analyst reports. Barclays initiated coverage on shares of Oscar Health in a report on Wednesday, July 2nd. They issued an “underweight” rating and a $17.00 target price on the stock. Wall Street Zen lowered Oscar Health from a “buy” rating to a “hold” rating in a research note on Sunday, June 8th. Raymond James Financial cut Oscar Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 24th. Piper Sandler lowered Oscar Health from an “overweight” rating to a “neutral” rating and set a $14.00 price objective on the stock. in a research note on Monday, July 14th. Finally, UBS Group reissued a “sell” rating and set a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Five investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company. Based on data from MarketBeat.com, Oscar Health presently has a consensus rating of “Reduce” and an average target price of $12.92.

Oscar Health Trading Down 3.3%

NYSE:OSCR opened at $13.41 on Friday. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.79. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 0.88. The firm’s fifty day moving average is $16.21 and its 200-day moving average is $14.91. The firm has a market cap of $3.42 billion, a P/E ratio of 47.89 and a beta of 1.90.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.09. The business had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The firm’s revenue for the quarter was up 42.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.62 earnings per share. Equities analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Insiders Place Their Bets

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the sale, the director directly owned 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 24.39% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.